Key result
Alpha-blocker therapy resolves atypical pheochromocytoma presenting with AMI, HF, and erythrocytosis in a 72-year-old man.
Why the study?
Atypical presentations of pheochromocytoma such as acute myocardial infarction, heart failure, cardiomyopathy, stroke, and transient erythrocytosis have been infrequently documented.
Case Report (n=1)
Pheochromocytoma can present atypically as type-2 myocardial infarction, heart failure, and transient erythrocytosis, which may resolve with alpha-adrenergic blockade.
BACKGROUND: Pheochromocytoma is a rare catecholamines-secreting tumor arising from chromaffin cells in the adrenal medulla. It classically presents with paroxysmal hypertension, headaches, palpitations, sweating, and metabolic disorders. Atypical presentations such as acute myocardial infarction, heart failure, cardiomyopathy, stroke, and transient erythrocytosis have been infrequently documented. CASE SUMMARY: We describe the case of a 72-year-old man diagnosed with pheochromocytoma presenting with non-ST segment elevation myocardial infarction, heart failure, and transient erythrocytosis with nonobstructed coronary arteries. This was his second heart attack. The patient was previously diagnosed with myocardial infarction, and an immense mass was found on the left adrenal gland 3 years prior. Based on clinical and laboratory findings, a diagnosis of pheochromocytoma was confirmed. His coronary angiogram showed nonobstructed coronary arteries except for a myocardial bridge in the left anterior descending branch. This was a form of type-2 myocardial infarction. The myocardial cell lesions were caused by sudden secretion of catecholamines by the pheochromocytoma. Even more atypically, his hemoglobin level was obviously elevated at admission, but after a few days of treatment with an alpha-adrenergic receptor blocker, it dropped to normal levels without additional treatment. CONCLUSION: Pheochromocytoma may be a cause of acute myocardial infarction, heart failure, and transient erythrocytosis.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2021) conducted a case report in Pheochromocytoma (n=1). Terazosin was evaluated. Treatment with an alpha-adrenergic receptor blocker resolved atypical pheochromocytoma presentations including acute myocardial infarction, heart failure, and transient erythrocytosis in a 72-year-old man.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: